Jason Douglas Wilson, Chief Financial Officer at REATA PHARMACEUTICALS INC (RETA), sold 4,000 shares at $88.74 ($360K) on 2019-05-15, disclosed to the SEC on 2019-05-17.
Open-market sale of $360k RETA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.74 | 900 | $80K | 22.2% |
| 2 | $89.82 | 1,600 | $144K | 40.0% |
| 3 | $90.70 | 1,500 | $136K | 37.8% |
| Total | $89.91 avg | 4,000 | $360K | 100% |
| Filing → |
| RETA | SELL | 2019-10-21 | $1.7M | — | Filing → |
| RETA | SELL | 2019-10-15 | $5.5M | — | Filing → |
| RETA | SELL | 2019-10-15 | $2.1M | — | Filing → |